Skip to Main Content

Paper Details

CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers.
bioRxiv
1
2023
CRISPR, Cancer, Cas9, PAM, Panc1002, Panc480, Panc504, T, cancer, co-cultures, esophageal cancer, noncoding regions, pancreatic cancer, pancreatic cancer cell lines, pancreatic cancers, patients, protospacer adjacent motif, sgRNAs, tumor, tumor-
Author NameAffiliation
Sarah J WheelanSidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine
Sarah J WheelanNational Human Genome Research Institute
Sarah J WheelanSidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine
Sarah J WheelanNational Human Genome Research Institute
  • 1 - 4

Datasets

Release 1.2